FIELD: medicine; pharmaceutics.
SUBSTANCE: group of inventions relates to pharmaceutical industry. Invention proposes a solid preparation for treating cancer in the form for oral administration, containing 20–80 wt./wt.% micronised 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile or a pharmaceutically acceptable salt thereof and an excipient selected from sugar, sugar alcohol and dicalcium phosphate; pharmaceutical preparation containing said solid preparation; method of producing said solid preparation by mixing an active agent and an excipient, followed by dry granulation of the obtained mixture; methods of producing a pharmaceutical preparation, which is a tablet or capsule; use of the pharmaceutical preparation in treating cancer.
EFFECT: group of inventions provides high content of the active agent in the preparation and improved bioavailability.
25 cl, 4 dwg, 2 tbl, 26 ex
Title | Year | Author | Number |
---|---|---|---|
COMBINATION OF 6-OXO-1,6-DIHYDRO-PYRIDAZINE DERIVATIVE HAVING ANTICOLIC ACTIVITY, WITH MEK INHIBITOR | 2013 |
|
RU2684407C2 |
COMBINATION OF 6-OXO-1,6-DIHYDRO-PYRIDAZINE DERIVATIVE HAVING ANTICANCER ACTIVITY WITH QUINAZOLINE DERIVATIVE | 2015 |
|
RU2704120C2 |
6-OXO-1,6-DIHYDRO-PYRIDAZINE DERIVATIVE FOR USE IN TREATMENT OF HEPATOCELLULAR CARCINOMA (HCC) | 2013 |
|
RU2650679C2 |
PHENOXYMETHYL HETEROCYCLIC COMPOUNDS | 2009 |
|
RU2531274C2 |
PHENOXYMETHYL DERIVATIVES | 2016 |
|
RU2746481C1 |
SWEET TASTE AND FLAVOUR MODIFIER | 2013 |
|
RU2666534C2 |
(3-CYCLOALKYL-2, 3, 4, 5 - TETRAHYDRO-1H-BENZO [d] AZEPIN-7-YLOXY) DERIVATIVES, USE THEREOF FOR INHIBITING H3 RECEPTORS, PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD | 2003 |
|
RU2388752C2 |
THERAPEUTIC ANTIDIABETIC AGENT | 2006 |
|
RU2438671C2 |
PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS PREPARATION | 2018 |
|
RU2767872C2 |
(1,10b-DIHYDRO-2-(AMINOALKYLPHENYL)-5H-PYRAZOLO[1,5-c][1,3] BENZOXAZIN-5-YL) PHENYLMETHANONE DERIVATIVES AS HIV VIRAL REPLICATION INHIBITORS | 2006 |
|
RU2416615C2 |
Authors
Dates
2024-07-01—Published
2020-07-08—Filed